Health NCCN Joins International Meeting to Improve Cancer Care in the Middle East and North Africa Region January 13, 2025
Health Timberlyne Therapeutics Launches with a $180 Million Series A Financing to Advance CM313, a Potentially Best-in-Class Anti-CD38 Monoclonal Antibody, for Diseases of High Unmet Medical Needs January 13, 2025
Health Astraveus Announces World First End-to-End Production of CAR-T Cells Using Microfluidic Technology January 9, 2025
Health Commit Biologics appoints accomplished R&D executive, Dr Janine Schuurman, to its Board of Directors January 8, 2025
Health China’s National Medical Products Administration (NMPA) Approves PADCEV™ in combination with KEYTRUDA® (pembrolizumab) for the Treatment of Advanced Bladder Cancer January 8, 2025